End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
227.7 ZAR | +0.46% | +3.18% | +11.90% |
Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.90% | 5.47B | B+ | ||
+19.98% | 43.48B | B- | ||
+20.67% | 22.65B | B+ | ||
+14.56% | 14.73B | - | ||
+14.32% | 13.79B | B+ | ||
+44.72% | 12.04B | B | ||
-8.37% | 7.08B | B+ | ||
-0.05% | 6.79B | - | - | |
-8.87% | 5.73B | - | - | |
-2.27% | 4.81B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- APN Stock
- Ratings Aspen Pharmacare Holdings Limited